The development of the collagenase inhibitor, cipemastat (Ro 32-3555), requ
ired the synthesis of both carbon-14 labelled and deuteriated material for
the measurement of the parent drug and drug-related material in biological
fluids. In addition, labelled metabolites were needed for both in vitro met
abolism and analytical studies. This paper describes the synthesis of label
led forms of cipemastat and its amide (Ro 32-4778) and glucuronide (Ro 32-6
414) metabolites,